SANUWAVE Health (SNWV) exec David Wern receives 2,500 stock options

Rhea-AI Filing Summary

SANUWAVE Health executive receives stock option grant

SANUWAVE Health, Inc. granted Exec VP of Sales David Timothy Wern a stock option for 2,500 shares of common stock on January 30, 2026. The option has an exercise price of $26.96 per share and expires on January 30, 2036.

The filing shows the full 2,500 options are held directly after the transaction. According to the footnote, these options will vest over three years in 12 equal quarterly installments starting from the grant date, tying the award to ongoing service and performance over time.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wern David Timothy

(Last) (First) (Middle)

9600 W. 76TH STREET

SUITE 118

(Street)

EDEN PRAIRIE MN 55344

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SANUWAVE Health, Inc. [ SNVW ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Exec VP of Sales

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to buy)	$26.96	01/30/2026		A		2,500		(1)	01/30/2036	Common Stock	2,500	$0	2,500	D

Explanation of Responses:

1. Options will vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date.

	/s/ Griffin D. Foster as Attorney-in-Fact for David Timothy Wern	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did SANUWAVE Health (SNWV) report for David Timothy Wern?

The company reported a stock option grant to Exec VP of Sales David Timothy Wern for 2,500 options. The award was granted on January 30, 2026 and represents a new equity incentive tied to his role at SANUWAVE Health.

What are the key terms of David Timothy Wern’s stock options at SANUWAVE Health (SNWV)?

The options allow purchase of 2,500 SANUWAVE Health common shares at an exercise price of $26.96 per share. They were granted on January 30, 2026 and expire on January 30, 2036, providing a ten-year exercise window.

How do David Timothy Wern’s SANUWAVE Health (SNWV) options vest over time?

The options will vest over three years in 12 equal installments. Vesting occurs on each quarterly anniversary of the January 30, 2026 grant date, gradually increasing his exercisable portion as he continues in his executive role.

How many SANUWAVE Health (SNWV) derivative securities does David Timothy Wern hold after this grant?

After the reported transaction, David Timothy Wern beneficially owns 2,500 stock options. The filing shows all of these derivative securities are held directly, reflecting the full amount from the January 30, 2026 grant.

What type of Form 4 transaction code applies to SANUWAVE Health (SNWV) executive David Timothy Wern?

The transaction is coded “A”, indicating an award or grant of derivative securities. This code confirms the 2,500 stock options were granted to David Timothy Wern rather than purchased or sold in the open market.

Does the SANUWAVE Health (SNWV) Form 4 show direct or indirect ownership for the options?

The Form 4 identifies the 2,500 stock options as held directly by David Timothy Wern. No trust, LLC, or other intermediary entity is listed in the ownership nature field for this specific derivative award.